NZ716687A - Il-18 binding molecules - Google Patents
Il-18 binding moleculesInfo
- Publication number
- NZ716687A NZ716687A NZ716687A NZ71668713A NZ716687A NZ 716687 A NZ716687 A NZ 716687A NZ 716687 A NZ716687 A NZ 716687A NZ 71668713 A NZ71668713 A NZ 71668713A NZ 716687 A NZ716687 A NZ 716687A
- Authority
- NZ
- New Zealand
- Prior art keywords
- binding molecules
- bind
- bound
- complex
- inflammatory diseases
- Prior art date
Links
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261697981P | 2012-09-07 | 2012-09-07 | |
NZ70482513 | 2013-09-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ716687A true NZ716687A (en) | 2017-03-31 |
Family
ID=58397952
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ716687A NZ716687A (en) | 2012-09-07 | 2013-09-05 | Il-18 binding molecules |
Country Status (1)
Country | Link |
---|---|
NZ (1) | NZ716687A (en) |
-
2013
- 2013-09-05 NZ NZ716687A patent/NZ716687A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2020007022A (en) | Il-18 binding molecules. | |
CL2014003110A1 (en) | Anti-fcrn antibody; sequences that encode it; vector; host cell; production process; pharmaceutical composition comprising it; use for the treatment of autoimmune disease; and assay to test the ability of an antibody to block human fcrn activity. | |
MX2010010387A (en) | Bcr-complex-specific antibodies and methods of using same. | |
MX2010009190A (en) | HUMANIZED ANTI-C5aR ANTIBODIES. | |
EA201492149A1 (en) | ST2 Antigen Binding Proteins | |
EA201291067A1 (en) | HUMANIZED ANTIGENSORATING PROTEINS FOR MYOSTATIN | |
MX356800B (en) | Humanized tau antibody. | |
EA201492137A1 (en) | ANTIBODIES TO CD33 AND THEIR APPLICATION IN CANCER TREATMENT | |
MX2014014218A (en) | Il-6 binding molecules. | |
SG10201808738WA (en) | Fusokines involving cytokines with strongly reduced receptor binding affinities | |
EA201790438A1 (en) | ANTIGEN-BINDING PROTEINS THAT CONNECT WITH CXCR5 | |
UA106529C2 (en) | Humanized antibodies to cxcr4 for cancer treatment | |
EP3085786A3 (en) | Use of aptamers in therapy and/or diagnosis of autoimmune diseases | |
MX2015005757A (en) | Her3 antigen binding proteins binding to the beta-hairpin of her3. | |
WO2015013508A3 (en) | Methods for diagnosing and treating immune disease | |
MX366046B (en) | Binding molecules that bind human complement factor c2 and uses thereof. | |
WO2013103899A3 (en) | Phosphorylation of histones and uses thereof | |
NZ716687A (en) | Il-18 binding molecules | |
WO2012119989A3 (en) | Antibodies against cadmi for the diagnosis and treatment of cancer | |
ES2481517A2 (en) | Method for the diagnosis of parkinson's disease in early stages (Machine-translation by Google Translate, not legally binding) | |
TH167242B (en) | Molecular adhesion IL-18 | |
TH167242A (en) | Molecular adhesion IL-18 | |
NZ768582A (en) | Antibodies and uses thereof to detect folate receptor 1 | |
TN2011000150A1 (en) | Anti cxcr4 antibodies and their use for the treatment of cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PSEA | Patent sealed | ||
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 05 SEP 2018 BY CPA GLOBAL Effective date: 20170817 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 05 SEP 2019 BY CPA GLOBAL Effective date: 20180816 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 05 SEP 2020 BY CPA GLOBAL Effective date: 20190822 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 05 SEP 2021 BY CPA GLOBAL Effective date: 20200820 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 05 SEP 2022 BY CPA GLOBAL Effective date: 20210819 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 05 SEP 2023 BY CPA GLOBAL Effective date: 20220818 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 05 SEP 2024 BY CPA GLOBAL Effective date: 20230817 |